The Total Synthesis of Pleurotin
The Total Synthesis of Pleurotin
批准号:
9467893
负责人:
Andrew Musacchio
金额:
$5.67万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-11 至 2019-09-10
关键词:
AntibioticsBindingBiologicalBiological AssayBiological TestingBiologyBreast Cancer CellCancer BiologyCarbonChemical StructureCollaborationsColon CarcinomaCyclizationCyclohexanesDevelopmentHT29 CellsHandHumanHypoxiaInvestigationIsotopesMCF7 cellMalignant Epithelial CellMalignant NeoplasmsNatural ProductsOxidation-ReductionPathway interactionsPleurotusPolyenesPrevalencePropertyProteolysisQuinonesReactionReportingResearchResearch ProposalsRouteSourceStructureSystemTestingVascular Endothelial Growth Factorsactivity-based protein profilinganalogangiogenesisantitumor agentbasecancer cellcancer therapycancer typechemical synthesisdecalindriving forceeffective therapyfight againsthypoxia inducible factor 1insightmigrationnovelnovel therapeuticspleuromutilinpleurotinscaffoldsmall molecule inhibitorthioredoxin reductasetranscription factortumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Development of novel cancer therapies that selectively target cancer cells through
mechanisms unique to cancer biology remains an important challenge in the fight against cancer.
This task is made even more difficult due to the vast number of different cancer types, each with its
own unique biology. However, certain biological pathways are common to many different varieties of
cancer, providing an opportunity for the development of a general therapy for cancer treatment. One
such pathway is hypoxia-induced angiogenesis, which has been suggested to be the driving force
for around 70% of human cancer types. Development of a selective small molecule inhibitor of this
pathway would represent a major step forward in cancer treatment, enabling effective treatment of a
diverse range of different cancer types.
Pleurotin is an antibiotic fungal metabolite first isolated in 1947 and found to possess
powerful anticancer properties. Despite being known for 70 years, the exact mechanism of
pleurotin’s anticancer effect remains unknown, although it is proposed to function through inhibition
of hypoxia-induced angiogenesis. This proposed biological mode of action has made pleurotin a
high value target for both biological studies and chemical synthesis. This research proposal
describes a short chemical synthesis of pleurotin through rapid formation of the challenging trans-
hydrindane motif found in the natural product. Due to the prevalence of trans-hydrindane structures
in a variety of natural products, this strategy should enable the synthesis of a wealth of molecules
with varied biological activity. The research plan also outlines the synthesis and biological testing of
novel pleurotin analogs. The combination of analog synthesis and biological assays will allow for the
elucidation of the mechanism of pleurotin’s anticancer properties, potentially leading to new general
treatments for cancer. Overall, the proposed research will allow for the rapid synthesis of an
important natural product and provide valuable information on the mechanism of inhibition of a
prevalent driving force in human cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: